Clinical trial NCT06611969: Inspiratory Muscle Training in Amateur Athletes
Official title: Effects of Inspiratory Muscle Training As a Complement to Usual Training on Respiratory Function and Performance in Amateur Athletes
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Amateur Athletes
Keywords: inspiratory muscle training
respiratory function
performance
exercise
Lead sponsor: University of Valencia
Sponsor class: OTHER
First posted: 2024-09-25
Enrollment: 38
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The main objective of the study is to study the changes in FEV1 with the introduction of the specific inspiratory muscle training programme in the training programme of the popular athletes included. In addition, the secondary aims are to observe the differences in the respiratory capacities of the patients, in the vital signs, VO2 max, respiratory frequency and cardiac variability, as well as to assess the running performance of the participants.

Participants will be assigned to one of 2 study groups: IMT group (n=20) or not-IMT group (n=20) The IMT group will perform inspiratory muscle training in conjunction with the conventional marathon training plan. The not-IMT group will follow only the conventional marathon training plan. The study will be conducted over a 12 week period.


Eligibility criteria: Inclusion Criteria:

* Individuals willing to follow the 16-week running training plan
* Possibility of combining aerobic training with inspiratory muscle training
* Previous half marathon runner

Exclusion Criteria:

* - Exclusive or professional dedication to athletics
* Previous or current use of respiratory muscle training.
* Inadequate or health risk physical condition
* Significant chronic cardiorespiratory diagnoses (e.g. moderate-severe COPD).
* Neurological, muscular or neuromuscular problems that interfere with the ability to participate in tests and training protocols.
* Discontinuity in the performance of training.
* A terminal illness or any other major medical contraindication
* Lack of informed consent

Primary outcomes:
measure: Expiratory forced volume in first second
timeFrame: Before starting the intervention and after its completion (12 weeks)
Secondary outcomes:
measure: Hearth rate variability
timeFrame: From the beginning to the end of the programme, recorded on a daily basis.
measure: Hearth rate
timeFrame: From the beginning to the end of the programme, recorded on a daily basis.
measure: Respiratory rate
timeFrame: From the beginning to the end of the programme, recorded on a daily basis.
measure: Running performance
timeFrame: From the beginning to the end of the programme, recorded on a daily basis.
measure: Maximal inspiratory pressure
timeFrame: Before starting the intervention and after its completion (12 weeks)
measure: Maximal consumption of oxygen
timeFrame: Before starting the intervention and after its completion (12 weeks)
Other outcomes:
Locations:
city: Valencia
country: Spain
facility: Valencia
Study officials:
affiliation: Universitat de Valencia, Spain
name: Francisco Miguel Martínez Arnau, PhD
role: STUDY_DIRECTOR
References: